Patent ID: 6537807
Filing Date: 2003-03-25
Classification: A61K,A61P,C12N,G01N

Abstract:
A population of CD34âˆ’CD7+Linâˆ’Linâˆ’ hemaotopoietic progenitors comprising greater than about 80% CD7+ cells wherein said CD7+ cells are characterized by a surface phenotype that is CD45RA+, glycophorin Aâˆ’, CD3âˆ’, CD2âˆ’, CD56âˆ’, CD24âˆ’, CD19âˆ’, CD66bâˆ’, CD14âˆ’, CD16âˆ’, CD38âˆ’, CD71âˆ’, CD33âˆ’, HLA-DRâˆ’, CD5âˆ’, CD4âˆ’, CD25âˆ’ and is capable of multilineage development.